High prevalence of antiphospholipid antibodies in leprosy: evaluation of antigen reactivity

Abstract

Antiphospholipid antibodies (aPL) have been reported not only in autoimmune disorders but also in various infectious diseases. Accumulating evidence indicates that b₂ glycoprotein I (b₂GPI) and prothrombin are the main proteins to which autoimmune aPL bind. The aim of this study was to evaluate the prevalence of different aPL in patients with leprosy. We included 51 outpatients (42 lepromatous and 9 borderline leprosy) without any clinical feature of the antiphospholipid syndrome (APS). 35 had lupus anticoagulant and 31 had anticardiolipin antibodies (aCL). Anti-β2GPI antibodies were highly positive in 29=51 and anti-prothrombin antibodies (anti-II) were detected in 23=51. Almost all aCL and anti-b₂GPI were of IgM isotype, while IgG isotype was more frequent among anti-II. No statistical difference was found when aPL were evaluated in patients grouped according to their bacteriological status. Furthermore, patients under treatment (n ‘ 33) had a similar frequency of positive aPL compared to patients in vigilance (n ‘ 14). Assessing the specificity of antibody binding to CL and b₂GPI in ELISA by means of inhibition studies with cardiolipin-b₂GPI liposomes, leprosy and APS sera showed a similar behaviour. Comparable results were also found in both groups of patients when inhibition experiments with lysate of Mycobacterium leprae were carried out. In summary, leprosy-related aPL resemble those found in patients with APS but the immunoglobulin isotype is different, with IgM much more prevalent in leprosy patients.

Keywords

leprosy lupus anticoagulant antiphospholipid antibodies anticardiolipin antibodies anti-β2 glycoprotein I antibodies

Get full access to this article

View all access options for this article.

References

Harris EN . The antiphospholipid syndrome <Eth> an introduction. In: Harris EN , Exner T , Hughes GRV , Asherson RA (eds). Phospholipid-Binding Antibodies. CRC Press FL: Boca Raton , 1991, pp 373–386.

Galli M , Comfurius P , Maassen C et al. Anticardiolipin antibodies (ACA) directed not to cardiolipin but to a plasma protein cofactor . Lancet 1990;335: 1544–1547 .

Roubey RAS . Immunology of the antiphospholipid syndrome . Arthritis Rheum 1996;39: 1444–1454 .

Roubey RAS , Eisenberg RA , Harper MF , Winfield JB . ‘Anticardiolipin’ autoantibodies recognize b2-Glycoprotein I in the absence of phospholipid. Importance of antigen density and bivalent binding . J Immunol 1995;154: 954–960 .

Arvieux J , Darnige L , Caron C et al. Development of an ELISA for autoantibodies to prothrombin showing their prevalence in patients with lupus anticoagulants . Thromb Haemost 1995;74: 1120–1125 .

Martinuzzo ME , Forastiero RR , Carreras LO . Anti b2-glycoprotein I antibodies:detection and association with thrombosis . Br J Haematol 1995;89: 397–402 .

Forastiero RR , Martinuzzo ME , Cerrato GS et al. Relationship of anti b2-glycoprotein I and anti prothrombin antibodies to thrombosis and pregnancy loss in patients with antiphospholipid antibodies . Thromb Haemost 1997;78: 1008–1014 .

Viard JP , Amoura Z , Bach JH . Association of anti b2-glycoprotein I antibodies with lupus-type circulating anticoagulant and thrombosis in systemic lupus erythematosus . Am J Med 1992;93: 181–186 .

Cabiedes J , Cabral AR , Alarcon-Segovia D . Clinical manifestations of the antiphospholipid syndrome in patients with systemic lupus erythematosus associate more strongly with anti-b2-glycoprotein-I than with antiphospholipid antibodies . J Rheumatol 1995;22: 1899–1906 .

10.

de Larrañaga GF , Forastiero RR , Carreras LO , Alonso BS. Different types of antiphospholipid antibodies in AIDS:a comparison with syphilis and the antiphospholipid syndrome . Thromb Res 1999;96: 19–25 .

11.

Abuaf N , Laperche S , Rajoely B et al. Autoantibodies to phospholipids and to the coagulation proteins in AIDS . Thromb Haemost 1997;77: 856–861 .

12.

Biron C , Andréani H , Blanc P et al. Prevalence of antiphospholipid antibodies in patients with chronic liver disease related to alcohol or hepatitis C virus:correlation with liver injury . J Lab Clin Med 1998;131: 243–250 .

13.

Leroy V , Arvieux J , Jacob MC et al. Prevalence and significance of anticardiolipin, anti-b2 glycoprotein I and anti-prothrombin antibodies in chronic hepatitis C . Br J Haematol 1998;101: 468–474 .

14.

Guedes Barbosa LS , Gilbrut B , Shoenfeld Y , Scheinberg MA. Autoantibodies in leprosy sera . Clin Rheumatol 1996;15: 26± 28 .

15.

Fiallo P , Travaglino C , Nunzi E , Cardo PP . b2-Glycoprotein Independence of anticardiolipin antibodies in multibacillary leprosy patients . Lepr Rev 1998;69: 376–381 .

16.

Hojnik M , Gilburd B , Ziporen L et al. Anticardiolipin antibodies in infections are heterogeneous in their dependency on b2-glycoprotein I:analysis of anticardiolipin antibodies in leprosy . Lupus 1994;3: 515–521 .

17.

Thawani G , Bhatia VN , Mukherjee A. Anticardiolipin antibodies in leprosy . Indian J Lepr 1994;66: 307–314 .

18.

Wang CR , Liu MF , Jeng GW et al. Autoantibodies and related immunity of leprosy patients from leprosarium in Taiwan . Chinese J Microbiol Immunol 1992;25: 181–188 .

19.

Furukawa F , Kashihara M , Imamura S et al. Evaluation of anticardiolipin antibody and its cross-reactivity in sera of patients with lepromatous leprosy . Arch Dermatol Res 1986;278: 317–319 .

20.

Brandt JT , Triplett DA , Alving B , Scharrer I . Criteria for the diagnosis of lupus anticoagulants:an update . Thromb Haemost 1995;74: 1185–1190 .

21.

Forastiero RR , Cerrato GS , Carreras LO . Evaluation of recently described tests for detection of the lupus anticoagulant . Thromb Haemost 1994;72: 728–733 .

22.

Harris EN. The Second International Anticardiolipin Standardization Workshop/The Kingston Antiphospholipid Study (KAPS) Group . Am J Clin Pathol 1990;94: 476–484 .

23.

Forastiero RR , Martinuzzo ME , Kordich LC , Carreras LO . Reactivity to b2 glycoprotein I clearly differentiates anticardiolipin antibodies from antiphospholipid syndrome and syphilis . Thromb Haemost 1996;75: 717–720 .

24.

Matsuda J , Saitoh N , Gohchi K et al. Distinguishing b2-glycoprotein I dependent (systemic lupus erythematosus type) and independent (syphilis type) anticardiolipin antibodies with Tween 20 . Br J Haematol 1993;85: 799–802 .

25.

Ordi J , Selva A , Monegal F et al. Anticardiolipin antibodies and dependence of a serum cofactor. A mechanism of thrombosis . J Rheumatol 1993;20: 1321–1324 .

26.

Cole FS , Brusch JL , Talarico L . A circulating anticoagulant in lepromatous leprosy . Int J Lepr 1979;47: 121–125 .

27.

Desai RG . An unusual case of Hansen's disease (lepromatous leprosy) with circulating anticoagulant and macroglobulinemia . Int J Lepr 1990;58: 462–465 .

28.

Galli M , Finazzi G , Bevers EM , Barbui T . Kaolin clotting time and dilute Russell's viper venom time distinguish between prothrombin dependent and b2-glycoprotein I-dependent antiphospholipid antibodies . Blood 1995;86: 617–623 .

29.

Forastiero RR , Martinuzzo ME , Carreras LO . Binding properties of antibodies to prothrombin and b2-glycoprotein I assayed by ELISA and Dot blot . Clin Exp Immunol 1999;118: 480–486 .

30.

Elbeialy A , Atsumi T , Amengual O et al. Antiphospholipid antibodies in leprotic patients:a correlation to vasculitic disease manifestations . Br J Rheumatol 1998;37: 89-89 (abstract 164).

31.

Guerin J , Feighery C , Sim RB , Jackson J. Antibodies to b2-glycoprotein I-a specific marker for the antiphospholipid syndrome . Clin Exp Immunol 1997;109: 304–309 .

32.

Vargas-Alarcon G , Yamamoto-Furusho JK , Zuniga J et al. HLA-DR7 in association with chlorpromazine-induced lupus anticoagulant (LA) . J Autoimmun 1997;10: 579–583 .

33.

Visvanathan S , McNeil HP . Cellular immunity to b2-glycoprotein-1 in patients with the antiphospholipid syndrome . J Immunol 1999;162: 6919–6925 .